Amazon Health AI’s digital front door may close the door on independent primary care

Amazon's Health AI platform is being marketed as a consumer convenience tool: an always-available, artificial intelligence (AI) assistant that can answer questions, explain medical records, manage prescription renewals, schedule appointments, and connect patients with clinicians. Independent primary care physicians should view it more strategically. It may become the digital front door to a vertically integrated health care system that controls the patient relationship before the patient ever contacts their own physician.

The threat is not that an AI chatbot will replace primary care doctors overnight. The more immediate danger is subtler: Amazon can capture low-acuity, high-frequency, commercially attractive care. It can steer patients toward their own clinical and pharmacy services and accumulate valuable health-behavior data. This can leave independent practices responsible for the costly, complicated, poorly reimbursed care that remains.

Amazon's advantage is not simply artificial intelligence. It is the company's capacity to combine AI, Prime membership, One Medical, virtual care, pharmacy fulfillment, consumer trust, and logistics into one frictionless experience. Independent primary care has survived managed care, hospital employment, private equity, retail clinics, and telehealth. Amazon may be more consequential because it is competing to own the consumer's first interaction with the health care system, not merely a single visit.

The digital front door

For decades, primary care practices have served as the patient's front door. Patients call the office, send a portal message, request a refill, or book an appointment with a clinician who knows their history. Those interactions create continuity and trust, and they provide the economic foundation for comprehensive primary care. Amazon Health AI is designed to intercept that first interaction.

Amazon says the platform can answer health questions, interpret records and lab results, assist with medication management, book appointments, and connect users to care — while steering consumers toward One Medical clinicians and Amazon's virtual-care services. Amazon has offered eligible Prime members up to five no-cost direct-message visits for more than 30 common conditions, followed by pay-per-visit virtual care starting around $29. This is not simply a useful AI feature; it is a sophisticated patient-acquisition strategy.

Imagine the patient with dysuria, a rash, reflux, cough, or a medication question at 10 p.m. Instead of calling the primary care office the next day, the patient asks Amazon. The platform gathers information, provides guidance, routes the patient to a clinician, facilitates a prescription, and may direct fulfillment to Amazon Pharmacy. For consumers, this may feel easier and faster. For independent primary care, it can be destabilizing.

The danger is not that Amazon necessarily provides superior longitudinal care. It is that Amazon becomes the habitual first stop for low-acuity, time-sensitive problems. Once that happens, the independent physician increasingly becomes the clinician patients see only when problems are complicated or beyond the platform's protocols. That is a poor clinical and economic arrangement for community practice.

Cherry-picking the easier work

Comprehensive primary care depends on a balanced mix of work: acute visits, preventive care, chronic disease follow-up, wellness visits, and complex diagnostic evaluation all support one another. Amazon's model can focus on encounters that are easiest to standardize and connect to prescriptions, promoting Health AI for common conditions including colds, flu, allergies, reflux, urinary tract infections, pink eye, erectile dysfunction, and hair loss.

These visits may not produce large margins individually, but they are frequent touchpoints that reinforce the primary care relationship and often reveal underlying problems. The patient asking for reflux medication may have anemia or poorly controlled diabetes. The patient requesting urinary tract infection treatment may have recurrent infection or resistant organisms. The patient seeking help for erectile dysfunction may have unrecognized cardiovascular risk.

In traditional primary care, these "simple" encounters occur within a longitudinal relationship where the physician sees the broader clinical context and problems trigger appropriate follow-up. When care is redirected through a separate corporate platform, the episode may be convenient but clinically fragmented: The independent physician may not know it occurred, medication lists may become inaccurate, and diagnostic delays can result.

Meanwhile, independent practices may retain a disproportionate share of patients with multimorbidity, frailty, behavioral-health conditions, and polypharmacy — the very patients who most need a trusted relationship and require more resources than fee-for-service payment usually supports. This is the central economic risk: Amazon can capture the scalable, consumer-friendly portions of primary care, while independent physicians carry the high-touch, undercompensated work.

AI magnifies scale advantages

Amazon Connect Health, an Amazon Web Services AI platform, is designed to support health care organizations with patient identification, scheduling, clinical documentation, coding, prior authorization, and care coordination. It is made to handle high-volume administrative work and integrate with clinical systems.

Independent practices should not reject these tools. They need them. AI can reduce inbox burden, summarize charts, support documentation, identify care gaps, streamline referrals, and improve coding accuracy. Used correctly, it could preserve physician autonomy by allowing smaller practices to operate more efficiently.

But the issue is who owns the AI layer. If Amazon controls the consumer-facing assistant, patient interface, and clinical routing, independent physicians risk becoming downstream suppliers rather than coordinators of care. Amazon does not need to own every physician office to reshape the market. It only needs to control where patients begin and how easily they move into Amazon-affiliated services. Large technology companies can spread AI, cybersecurity, marketing, and infrastructure costs across millions of customers. An independent practice cannot easily compete with subsidized services and round-the-clock digital access. Patients do not compare corporate strategy. They compare convenience, and Amazon is building for precisely those moments.

Combining data and market power

Health AI becomes more useful as it gains access to medications, diagnoses, and lab results. Amazon says its Health AI can use connected health information for personalized assistance, that conversations aren't automatically added to the medical record, and that protected health information isn't used to market general merchandise. Those commitments matter, but they don't resolve the broader concern about concentration of health care data and market influence. A platform that sees a patient's questions, symptoms, and care-seeking patterns learns not only what patients need medically, but when they seek care and which pathways retain them.

The Federal Trade Commission allowed Amazon's $3.9 billion acquisition of One Medical to close in 2023, but commissioners raised concerns about sensitive health information and the competitive implications of combining a major consumer platform with a primary care organization. Those concerns intensify in an AI-driven environment, where the question is no longer just who holds a record, but who uses algorithms to interpret it and direct the next transaction. Even if every data practice is technically lawful, this concentration should concern physicians and policymakers.

Who controls the patient journey?

Primary care is the coordinating center of health care: deciding when a symptom can be managed conservatively, whether a prescription is appropriate, which specialist is needed, and when in-person follow-up is required. Amazon is assembling the tools to influence each part of that process.

One Medical offers in-person and virtual primary care, secure messaging, and referral management, while Amazon Pharmacy provides an integrated fulfillment channel. Health AI can sit atop this funnel: It captures the initial patient question, recommends a care pathway, routes the encounter to an Amazon-affiliated clinician, fills the prescription through Amazon Pharmacy, and prompts follow-up. All those feed data back to retain the patient relationship.

This is vertical integration, even if it doesn't resemble a hospital acquisition. The patient sees convenience; the independent practice sees fewer routine contacts, less data, and less negotiating leverage. Amazon may not need to explicitly direct patients away from community physicians. Simply making its own services easier to access may be enough.

What should independent practices do?

The answer is not to defend outdated access models. Patients are justified in expecting timely communication, digital scheduling, virtual care, and convenient medication services. Independent primary care must compete on access without surrendering its core advantage: a trusted, longitudinal physician-patient relationship.

• First, every practice needs a credible digital front door. That means online scheduling, rapid portal response, same-day access, and clear after-hours options. If patients cannot reach their own primary care team conveniently, they will reach Amazon.
• Second, practices should deploy AI as infrastructure, not a substitute for clinical relationships. AI can and should support chart review, documentation, coding, and referrals, freeing physicians for complex human work rather than ceding the patient interaction to an outside platform.
• Third, independent practices should build scale through independent practice associations, clinically integrated networks, accountable care organizations, and physician-led collaborations. Technology, contracting, analytics, and value-based care operations are expensive; independent physicians need collective infrastructure to compete without selling their practices.
• Fourth, physicians should demand meaningful interoperability, so care delivered through outside platforms, pharmacies, and AI-assisted services flows quickly into the patient's longitudinal record rather than becoming one-way extraction into a corporate ecosystem.
• Finally, policymakers should recognize that health care AI is fundamentally a market-structure issue. Antitrust scrutiny, data protections, referral transparency, and limits on self-preferencing will matter. The question is not whether AI can make care easier — it clearly can. The question is whether that convenience will strengthen accountable, relationship-based primary care, or turn primary care into a customer-acquisition channel for a trillion-dollar platform.

AI may improve access for many patients, but no independent physician should mistake it for a neutral digital tool. It is a bid to own health care’s front door: the first question, the first clinical interaction, the prescription, the referral, and eventually the patient relationship itself. The threat is not an abrupt Amazon takeover of primary care, but a gradual erosion of patient relationships, routine encounters, and revenue base that sustain independent practices. More importantly, it may displace the patient loyalty that makes comprehensive independent practice possible.

Robert Resnik, M.D., MBA, is a board-certified internal medicine physician practicing in Cary, North Carolina. He earned his medical degree from Eastern Virginia Medical School and completed his residency at East Carolina University. He also holds an MBA from Duke University.